Search research articles
Contact Us
Filters
Showing results (21-30 of 119) with videos related to
Page
of 12
Sort By:
Psychoneuroendocrinology
|
March 26, 2003
Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents
U Naidoo, D C Goff, A Klibanski
Acta Psychiatrica Scandinavica
|
June 8, 2004
Insight into current symptoms of schizophrenia. Association with frontal cortical function and affect
O Freudenreich, T Deckersbach, D C Goff
The Journal of Clinical Psychiatry
|
July 1, 1988
Postpartum panic disorder
A Metz, D A Sichel, D C Goff
The American Journal of Psychiatry
|
September 1, 1992
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
D C Goff, D C Henderson, E Amico
CNS Spectrums
|
August 26, 2004
Augmentation strategies in the treatment of schizophrenia
D C Goff, O Freudenreich, A E Evins
Dermatology Online Journal
|
May 1, 2001
Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular disease
A S Katz, D C Goff, S R Feldman
The Journal of Clinical Psychiatry
|
September 1, 1985
Partial resolution of ranitidine-associated delirium with physostigmine: case report
D C Goff, H J Garber, M A Jenike
The Journal of Clinical Psychiatry
|
December 23, 1998
Switching from clozapine to olanzapine in treatment-refractory schizophrenia: safety, clinical efficacy, and predictors of response
D C Henderson, R A Nasrallah, D C Goff
The American Journal of Psychiatry
|
March 1, 1994
A placebo-controlled trial of trihexyphenidyl in unmedicated patients with schizophrenia
D C Goff, E Amico, D Dreyfuss, et al.
The American Journal of Psychiatry
|
April 1, 1990
Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients
D C Goff, A W Brotman, M Waites, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 119) with videos related to
Sort By:
Page
of 12
Psychoneuroendocrinology
|
March 26, 2003
Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents
U Naidoo, D C Goff, A Klibanski
Acta Psychiatrica Scandinavica
|
June 8, 2004
Insight into current symptoms of schizophrenia. Association with frontal cortical function and affect
O Freudenreich, T Deckersbach, D C Goff
The Journal of Clinical Psychiatry
|
July 1, 1988
Postpartum panic disorder
A Metz, D A Sichel, D C Goff
The American Journal of Psychiatry
|
September 1, 1992
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
D C Goff, D C Henderson, E Amico
CNS Spectrums
|
August 26, 2004
Augmentation strategies in the treatment of schizophrenia
D C Goff, O Freudenreich, A E Evins
Dermatology Online Journal
|
May 1, 2001
Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular disease
A S Katz, D C Goff, S R Feldman
The Journal of Clinical Psychiatry
|
September 1, 1985
Partial resolution of ranitidine-associated delirium with physostigmine: case report
D C Goff, H J Garber, M A Jenike
The Journal of Clinical Psychiatry
|
December 23, 1998
Switching from clozapine to olanzapine in treatment-refractory schizophrenia: safety, clinical efficacy, and predictors of response
D C Henderson, R A Nasrallah, D C Goff
The American Journal of Psychiatry
|
March 1, 1994
A placebo-controlled trial of trihexyphenidyl in unmedicated patients with schizophrenia
D C Goff, E Amico, D Dreyfuss, et al.
The American Journal of Psychiatry
|
April 1, 1990
Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients
D C Goff, A W Brotman, M Waites, et al.
Page
of 12